You are here: Industry Insights > COVID-19 Vaccine

News List

UK teams up with Wockhardt for vaccine manufacturing services pharmaceutical-technology
August 04, 2020
The UK Government has partnered with India-based pharmaceutical company Wockhardt for ‘fill and finish’ services to boost vaccine manufacturing in the UK.
Emergent BioSolutions Signs Agreement with AstraZeneca contractpharma
August 04, 2020
Emergent BioSolutions Inc. has signed an agreement to provide contract development and manufacturing (CDMO) services for large-scale commercial drug substance manufacturing for AstraZeneca’s COVID-19 vaccine candidate, AZD1222.
Serum Institute of India gets DCGI nod for phase 2 and 3 human trials of Oxford vaccine candidate expresspharma
August 04, 2020
As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals.
Wockhardt signs partnership with UK Government to fill-finish COVID-19 vaccine expresspharma
August 04, 2020
The manufacturing will be undertaken at CP Pharmaceuticals, a subsidiary of Wockhardt based in Wrexham, North Wales.
J&J begins first trial of Covid-19 vaccine after positive preclinical data pharmaceutical-technology
August 03, 2020
Johnson & Johnson (J&J) has started a Phase I/IIa clinical trial of its Covid-19 vaccine candidate, Ad26.COV2.S, in healthy volunteers across the US and Belgium.
US commits $2.1bn for 100 million Sanofi-GSK Covid-19 vaccine doses pharmaceutical-technology
August 03, 2020
The US Government has committed to providing up to $2.1bn to Sanofi and GlaxoSmithKline (GSK) for development, manufacturing, scale-up and delivery of an initial 100 million doses of the companies’ Covid-19 vaccine candidate.
Policymakers to identify groups of people who will get priority for COVID-19 vaccine expresspharma
August 03, 2020
Four major challenges await India once a vaccine is available, i.e. prioritisation and fair distribution to vulnerable groups; logistics of vaccine rollout, including cold chain; stockpiling and training people who will administer this vaccine: ICMR Head.
J&J begins human trials of COVID-19 vaccine expresspharma
August 03, 2020
It will test its vaccine candidate in more than 1,000 healthy adults aged 18 to 55 years, as well as adults aged 65 years and older.
Pfizer and BioNTech sign deal with Japan for 120 mn doses of mRNA-based COVID-19 vaccine expresspharma
August 03, 2020
The companies have begun a Phase 2b/3 safety and efficacy trial and remain on track to seek regulatory review as early as October 2020.
GAVI’s new drive for COVID-19 vaccine access in LMIC countries includes India expresspharma
August 03, 2020
The list of 92 AMC-eligible economies includes all economies with GNI per capita under $4,000 plus other World Bank International Development Association eligible economies.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page